Herpes zoster infection as an immune reconstitution inflammatory syndrome in HIV-seropositive subjects: a review

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 104, Issue 4, 2007, Pages 455-460

  Feller, Liviu ^a   Wood, Neil H ^a   Lemmer, Johan ^a  

^a SEFAKO MAKGATHO HEALTH SCIENCES UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

AIDS RELATED COMPLEX; ARTICLE; CD8+ T LYMPHOCYTE; HERPES ZOSTER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; INFLAMMATION; PHYSIOLOGY; SYNDROME;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD8-POSITIVE T-LYMPHOCYTES; HERPES ZOSTER; HIV INFECTIONS; HUMANS; IMMUNE SYSTEM; IMMUNOLOGIC MEMORY; INFLAMMATION; SYNDROME;

EID: 34648836769     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2007.02.001     Document Type: Article

References (63)

1. Cheng V.C., Yuen K.Y., Chan W.M., Wong S.S., Ma E.S., and Chan R.M. Immunorestitution disease involving the innate and adaptive response. Clin Infec Dis 30 (2000) 882-892
2. Fauci A.S., and Lane H.C. Human immunodeficiency virus disease: AIDS and related disorders. In: Kasper D.L., Braunwald E., Fauci A.S., Hauser S.L., Longo D.L., and Jameson J.L. (Eds). Harrison's principles of internal medicine. 16th ed. (2005), McGraw-Hill, New York 1076-1139
3. Shelburne S.A., Visnegarwala F., Darcourt J., Graviss E.A., Giordano T.P., White Jr. A.C., et al. Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS 19 (2005) 399-406
4. Lawn S.D., Bekker L.G., and Miller R.F. Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals. Lancet Infect Dis 5 (2005) 361-373
5. French M.A. Antiretroviral therapy immune restoration disease in HIV-infected patients on HAART. AIDS Read 9 (1999) 548-562
6. French M.A., and Price P. Immune restoration disease in HIV-infected patients after antiretroviral therapy. Clin Infect Dis 32 (2001) 325-326
7. Dunic I., Djurkovic-Djakovic O., Vesic S., Zerjav S., and Jevtovic D. Herpes zoster as an immune restoration disease in AIDS patients during therapy including protease inhibitors. Int J STD AIDS 16 (2005) 475-478
8. DeSimone J.A., Pomerantz R.J., and Babinchak T.J. Inflammatory reactions in HIV-1 infected persons after initiation of highly active retroviral therapy. Ann Intern Med 133 (2000) 447-454
9. French M.A., Lenzo N., John M., Mallal S.A., McKinnon E.J., James I.R., et al. Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy. HIV Med 1 (2000) 107-115
10. French M.A., Price P., and Stone S.F. Immune restoration disease after antiretroviral therapy. AIDS 18 (2004) 1615-1627
11. Handa S., and Bingham J.S. Dermatological immune restoration syndrome: Does it exist?. J Eur Acad Dermatol Venereol 15 (2001) 430-432
12. Shelburne III S.A., and Hamill R.J. The immune reconstitution inflammatory syndrome. AIDS Rev 5 (2003) 67-79
13. Shelburne III S.A., Hamill R.J., Rodriguez-Barradas M.C., Greenberg S.B., Atmar R.L., Musher D.W., et al. Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy. Medicine 81 (2002) 213-227
14. Jevtovic D.J., Salemovic D., Ranin J., Pesic L., Zerjav S., and Djurkovic-Djakovic O. The prevalence and risk of immune restoration disease in HIV-infected patients treated with highly active antiretroviral therapy. HIV Medicine 6 (2005) 140-143
15. Price P., Morahan G., Huang D., Stone E., Heong K.Y., Castley A., et al. Polymorphism in cytokine genes define subpopulations of HIV-1 patients who experienced immune restoration diseases. AIDS 16 (2002) 2043-2047
16. John M., Flexman J., and French M.A. Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitor: an immune restoration disease?. AIDS 12 (1998) 2289-2293
17. Leidner R.S., and Aboulafia D.M. Recrudescent Kaposi's sarcoma after initiation of HAART: a manifestation of immune reconstitution syndrome. AIDS Patient Care STDS 19 (2005) 635-644
18. Domingo P., Torres O.H., Ris J., and Vasquez G. Herpes zoster as an immune reconstitution disease after initiation of combination antiretroviral therapy in patients with human immunodeficiency virus type-1 infection. Am J Med 110 (2001) 605-609
19. Martinez E., Gatell J., Moran Y., Aznar E., Buira E., Guelar A., et al. High incidence of herpes zoster in patients with AIDS soon after therapy with protease inhibitors. Clin Infec Dis 27 (1998) 1514-1516
20. Aldeen T., Hay P., Davidson F., and Lau R. Herpes zoster infection in HIV-seropositive patients associated with highly active antiretroviral therapy. AIDS 12 (1998) 1719-1720
21. Imami N., Antonopoulos C., Hardey G.A., Gazzard B., and Gotch F.M. Assessment of type 1 and type 2 cytokines in HIV type 1-infected individuals: impact of highly active antiretroviral therapy. AIDS Res Hum Retroviruses 15 (1999) 1499-1508
22. Lane H.C., and Fauci A.S. Immunologic reconstitution in the acquired immunodeficiency syndrome. Ann Intern Med 103 (1985) 714-718
23. Murray H.W., Rubin B.Y., Masur H., and Roberts R.B. Impaired production of lymphokines and immune (gamma) interferon in the acquired immunodeficiency syndrome. N Engl J Med 310 (1984) 883-889
24. Epstein J.S., Frederick W.R., Rook A.H., Jackson L., Manischewitz J.F., Mayner R.E., et al. Selective defects in cytomegalovirus- and mitogen-induced lymphocyte proliferation and interferon release in patients with acquired immunodeficiency syndrome. J Infect Dis 152 (1985) 727-733
25. Koot M., van 't Wout A.B., Kootstra N.A., de Goede R.E., Tersmette M., and Schuitemaker H. Relation between changes in cellular load, evolution of viral phenotype, and the clonal expansion of virus populations in the course of human immunodeficiency virus type 1 infection. J Infect Dis 173 (1996) 349-354
26. Mellors J.W., Rinaldo Jr. C.R., Gupta P., White R.M., Todd J.A., and Kinglsey L.A. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272 (1996) 1167-1170
27. Feller L., and Lemmer J. Necrotizing gingivitis as it relates to HIV infection: a review of the literature. Perio 2 (2005) 31-37
28. Erard F., Dunbar P.R., and Le Gros G. The IL-4 induced switch of CD8+ T cells to a Th2 phenotype and its possible relationship to the onset of AIDS. Res Immunol 145 (1994) 643-646
29. Barcellini W., Rizzardi G.P., Borghi M.O., Fain C., Lazzarin A., and Meroni P.L. Th1 and Th2 cytokine production by peripheral blood mononuclear cells from HIV-infected patients. AIDS 8 (1994) 757-762
30. Clerici M., and Shearer G.M. The Th1-Th2 hypothesis of HIV infection: New insights. Immunol Today 15 (1994) 575-581
31. Clerici M., and Shearer G.M. A Th1→Th2 switch is a critical step in the aetiology of HIV infection. Immunol Today 14 (1993) 107-111
32. Clerici M., Wynn T.A., Berzofsky J.A., Blatt S.P., Hendrix C.W., Sher A., et al. Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J Clin Invest 93 (1994) 768-775
33. Spellberg B., and Edwards Jr. J.E. Type 1/type 2 immunity in infectious diseases. Clin Infect Dis 32 (2001) 76-102
34. Palella Jr. F.J., Delaney K.M., Moorman A.C., Loveless M.O., Fuhrer J., Satten G.A., et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 338 (1998) 853-860
35. Kaplan J.E., Hanson D., Dworkin M.S., Frederick T., Bertolli J., Lindegren M.L., et al. Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active retroviral therapy. Clin Infect Dis 30 Suppl 1 (2000) S5-S14
36. Patton L.L. HIV disease. Dent Clin North Am 47 (2003) 467-492
37. Richman D.D. HIV chemotherapy. Nature 410 (2001) 995-2001
38. Paul S., Gilbert H.M., Ziecheck W., Jacobs J., and Sepkowitz K.A. The impact of potent antiretroviral therapy on the characteristics of hospitalized patients with HIV infection. AIDS 13 (1999) 415-418
39. Ho D.D., Neumann A.U., Perelson A.S., Chen W., Leonard J.M., and Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373 (1995) 123-126
40. Wei X., Ghosh S.K., Taylor M.E., Johnson V.A., Emini E.A., Deutsch P., et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373 (1995) 117-122
41. Patton L.L., McKaig R., Strauss R., Rogers D., and Erron Jr. J.J. Changing prevalence of oral manifestation of human immunodeficiency virus in the area of protease inhibitor therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 89 (2000) 299-304
42. Schmidt-Westhausen A.M., Priepke F., Bergmann F.J., and Reichart P.A. Decline in the rate of oral opportunistic infections following introduction of highly active antiretroviral therapy. J Oral Pathol Med 29 (2000) 336-341
43. Autran B., Carcelain G., Li T.S., Blanc C., Mathez D., Tubiana R., et al. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 277 (1997) 112-116
44. Li T.S., Tubiana R., Katlama C., Calvez V., Ait Mohand H., and Autran B. Long-lasting recovery in CD4+ T cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease. Lancet 351 (1998) 1682-1686
45. Hejdeman B., Lenkei R., Leandersson A.C., Hultstrom A.L., Wahren B., Sandstrom E., et al. Clinical and immunological benefits from highly active antiretroviral therapy in spite of limited viral load reduction in HIV type 1 infection. AIDS Res Hum Retroviruses 17 (2001) 277-286
46. Pakker N.G., Notermans D.W., de Boer R.J., Roos M.T., de Wolf F., Hill A., et al. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite redistribution and proliferation. Nat Med 4 (1998) 208-214
47. Kelleher A.D., Carr A., Zaunders J., and Cooper D.A. Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir. J Infect Dis 173 (1996) 321-329
48. Schnittman S.M., and Fox L. Preliminary evidence for partial restoration of immune function in HIV type 1 infection with potent antiretroviral therapies: clues from the Fourth Conference on Retroviruses and Opportunistic Diseases. AIDS Res Hum Retroviruses 13 (1997) 815-818
49. Connors M., Kovacs J.A., Krevat S., Gea-Banacloche J.C., Sneller M.C., Flannigan M., et al. HIV infection induces changes in CD4+ T-cell phenotyhpe and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiretroviral or immune-based therapies. Nature Med 3 (1997) 533-540
50. Wolthers K.C., Bea G., Wisman A., Otto S.A., de Roda Husman A.M., Schaft N., et al. T cell telomere length in HIV-1 infection: no evidence for increased CD4+ T cell turnover. Science 274 (1996) 1543-1547
51. Rosenberg E.S., Billingsley J.M., Caliendo A.M., Boswell S.L., Sax P.E., Kalams S.A., et al. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science 278 (1997) 1447-1450
52. Rosenberg E.S., and Walker B.D. HIV type 1-specific helper T cells: a critical host defence. AIDS Res Hum Retroviruses 14 (1998) S143-S147
53. Matloubian M., Concepcion R.J., and Ahmed R. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J Virol 68 (1994) 8056-8063
54. Mackewicz C.E., Blackbourn D.J., and Levy J.A. CD8+ T cells suppress human immunodeficiency virus replication by inhibiting viral transcription. Proc Natl Acad Sci U S A 92 (1995) 2308-2312
55. Feller L., and Jadwat Y. Herpes zoster. A. Review of the literature and report of a case. SADJ 60 (2005) 380-384
56. Strauss S.E., and Oxman M.N. Varicella and herpes zoster. In: Freedberg I.M., Elsen A.Z., Wolf K., Austen K.F., Goldsmith L.A., Katz S.I., and Fitzpatrick T.B. (Eds). Fitzpatrick's dermatology in general medicine. 5th ed. (1999), McGraw-Hill, New York 2427-2450
57. Eversole L.R. Viral infections of the head and neck among HIV-seropositive patients. Oral Surg Oral Med Oral Pathol 73 (1992) 155-163
58. Van Heerden W.F., McEachen S.E., and Boy S.C. Alveolar bone necrosis and tooth exfoliation secondary to herpes zoster in the setting of HIV/AIDS. AIDS 19 (2005) 2183-2184
59. Arvin A.M. Varicella-zoster virus. Clin Microbiol Rev 9 (1996) 361-381
60. Hung C.C., Hsiao C.F., Wang J.L., Chen M.Y., Hsieh S.M., Sheng W.H., et al. Herpes zoster in HIV-1 infected patients in the era of highly active antiretroviral therapy: a prospective observational study. Int J STD AIDS 16 (2005) 673-676
61. Robertson J., Meier M., Wall J., Ying J., and Fichtenbaum C.J. Immune reconstitution syndrome in HIV: validating a case definition and identifying clinical predictors in persons initiating antiretroviral therapy. Clin Infect Dis 42 (2006) 1639-1646
62. Michelet C., Arvieux C., Francois C., Besnier J.M., Rogez J.P., Breux J.P., et al. Opportunistic infections occurring during highly active antiretroviral treatment. AIDS 12 (1998) 1815-1822
63. Whitely R.J. Varicella-zoster virus infections. In: Kasper D.J., Braunwald E., Fauci A.S., Hauser S.L., Longo D.L., and Jameson J.L. (Eds). Harrison's principles of internal medicine. 16th ed. (2005), McGraw-Hill, New York 1042-1045